InvestorsHub Logo

alexander77

02/14/19 5:48 PM

#2193 RE: Klinsmann #2192

I agree. 5 million MC, if the P3 design is approved it’ll be very likely P3 will be succesfull. With potential annual revenues of upto $400m, market cap will explode.

alexander77

02/15/19 12:18 PM

#2194 RE: Klinsmann #2192

Since Wall Street is closed on Monday,it could be Tuesday PM when we get the news.

alexander77

02/20/19 7:49 AM

#2196 RE: Klinsmann #2192

Jackpot! ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug
“we believe Gencaro could potentially provide a new standard of treatment for AF prevention for the estimated 2.5 million HFmrEF patients in the major markets in U.S., Europe and Japan” P was 0.017! And 58% better results than the actieve comparator In P2!”

Should go to $2-4/share now with only 14million shares outstanding



https://finance.yahoo.com/news/arca-biopharma-announces-fda-agreement-123000757.html